Abbott has announced that the US Food and Drug Administration (FDA) has approved the FreeStyle Libre 14 day Flash Glucose Monitoring system, which allows people with diabetes to wear the sensor up to 14
More From BioPortfolio on "Abbott's FreeStyle Libre 14 day flash glucose monitoring system gets US FDA nod"